The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...
RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...
The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...
Brits have seen the winter flu season start earlier and an NHS director has said that we could be facing one of the worst ...
Virginia is experiencing a high number of hospitalizations for respiratory illnesses, according to data from the Virginia ...
Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...
Patients and visitors at hospitals across south Wales are being told to wear masks to control the spread of infection amid ...
Health officials continue to encourage vaccinations to help prevent severe illnesses from influenza, RSV and COVID-19.
Mask requirements and visitor restrictions have been implemented at OSF HealthCare hospitals to help slow the spread of respiratory illnesses.
BARS-13 is under clinical development by Beijing Advaccine Biotechnology and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections.